Pablo A. Silveira
- Immunology top 2%
- Genetics top 2%
- Surgery top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Oncology
- Co-authors
- Alan G. BaxterLynn D. PoultonDale I. GodfreyDavid SerrezeRobert BrinkFabienne MackayKirsten J. L. HammondShane T. Grey
- Topics
- T-cell and B-cell Immunology (26 papers)Diabetes and associated disorders (25 papers)Immune Cell Function and Interaction (22 papers)
- Partner nations
- AustraliaUnited StatesSpain
In The Last Decade
Pablo A. Silveira
56 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 86
- Immunology 1.4k
- Genetics 763
- Surgery 435
- Endocrinology, Diabetes and Metabolism 226
- Oncology 201
Countries citing papers authored by Pablo A. Silveira
This map shows the geographic impact of Pablo A. Silveira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo A. Silveira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo A. Silveira more than expected).
Fields of papers citing papers by Pablo A. Silveira
This network shows the impact of papers produced by Pablo A. Silveira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo A. Silveira. The network helps show where Pablo A. Silveira may publish in the future.
Co-authorship network of co-authors of Pablo A. Silveira
This figure shows the co-authorship network connecting the top 25 collaborators of Pablo A. Silveira. A scholar is included among the top collaborators of Pablo A. Silveira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo A. Silveira. Pablo A. Silveira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 9 | |
| 6 | 20 | |
| 7 | 8 | |
| 8 | 42 | |
| 9 | 7 | |
| 10 | 21 | |
| 11 | 25 | |
| 12 | Temporal depletion of B cells, by selectively targeting BAFF, prevents diabetes in NOD mice | 1 |
| 13 | 14 | |
| 14 | 22 | |
| 15 | 131 | |
| 16 | 34 | |
| 17 | 34 | |
| 18 | 122 | |
| 19 | The genus Festuca L. in the Açor and Lousã mountains. | 1 |
| 20 | 33 |
About Pablo A. Silveira
Pablo A. Silveira is a scholar working on Immunology, Genetics and Endocrinology, Diabetes and Metabolism, having authored 57 papers that have together received 2.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (26 papers), Diabetes and associated disorders (25 papers) and Immune Cell Function and Interaction (22 papers). The work is most often cited by research in Immunology (1.4k citations), Genetics (763 citations) and Endocrinology, Diabetes and Metabolism (226 citations). Pablo A. Silveira has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include Alan G. Baxter, Lynn D. Poulton, Dale I. Godfrey, David Serreze, Robert Brink, Fabienne Mackay, Kirsten J. L. Hammond, Shane T. Grey, Harold D. Chapman and Ellis Johnson. Their work appears in journals such as The Journal of Experimental Medicine, Immunity and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.